HB 7042 – Rhode Island

Status: In Process
Year Introduced: 2024
Link: http://webserver.rilegislature.gov/BillText/BillText24/HouseText24/H7042.pdf

This act would regulate price increases for prescription drugs. Any unsupported price increase of a prescription drug would be subject to a penalty equal to eight percent (80%) of the difference between the revenue generated by the sales of the prescription drug and the revenue that would have been generated if the manufacturer had maintained the wholesale acquisition cost from the previous calendar year, adjusted appropriately for inflation. Manufacturers would be prohibited from withdrawing a prescription drug from sale or distribution for the sole purpose of avoiding the penalty of a price increase.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found